Closing the Osteoporosis Care Gap.
Kristina E Åkesson1,2, Fiona E A McGuigan3,4
1Department of Clinical Sciences Malmö, Lund University, Lund, Sweden. kristina.akesson@med.lu.se.
Current Osteoporosis Reports
|January 9, 2021
Summary
Osteoporosis remains underdiagnosed and undertreated despite available medications. Implementing systematic fracture prevention programs, including dedicated coordinators and falls prevention, can effectively reduce re-fracture rates, especially in frail elderly individuals.
Area of Science:
- Gerontology
- Orthopedics
- Public Health
Background:
- Osteoporosis care and secondary fracture prevention face significant challenges, with underdiagnosis and undertreatment persisting despite increased awareness and effective medications.
- A gap in osteoporosis care continues despite available knowledge and treatments.
Purpose of the Study:
- To review the scope of osteoporosis-related problems and secondary fracture prevention.
- To describe effective fracture prevention strategies, emphasizing frail elderly populations.
Main Methods:
- Review of current literature on osteoporosis care and fracture prevention strategies.
- Focus on systematic risk assessment and secondary prevention programs.
Main Results:
- Systematic risk assessment and secondary fracture prevention programs are gaining momentum with accumulating evidence of success.
- Key components for secondary prevention include a dedicated fracture coordinator, anti-osteoporosis medications, and multifaceted falls prevention.
- Structured care pathways encompassing identification, investigation, intervention, and adherence follow-up demonstrably reduce re-fracture rates and are cost-effective.
Conclusions:
- The knowledge to close the osteoporosis care gap is available.
- Implementing structured secondary prevention models can significantly improve outcomes and reduce re-fracture rates, particularly in the frail elderly.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
118
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
118
Osteoclasts in Bone Remodeling
3.5K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.5K
Bone Remodeling
39.5K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
39.5K
Bone Disorders
4.9K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.9K
Coronary Artery Disease V: Interprofessional Care
126
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
126
Chronic Kidney Disease III: Interprofessional Care
206
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
206

